These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6226851)

  • 1. Erythrocyte anomalies in Down's syndrome.
    Bartosz G; Kedziora J
    Med Hypotheses; 1983 Aug; 11(4):471-7. PubMed ID: 6226851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural modifications of the erythrocyte membrane in Down's syndrome.
    Kedziora J; Koter M; Bartel H; Bartosz G; Leyko W; Jeske J
    Acta Biol Med Ger; 1981; 40(4-5):423-8. PubMed ID: 6274112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging of the erythrocyte. VI. Accelerated red cell membrane aging in Down's syndrome?
    Bartosz G; Soszyński M; Kedziora J
    Cell Biol Int Rep; 1982 Jan; 6(1):73-7. PubMed ID: 6459857
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythrocyte glycohydrolases in subjects with trisomy 21: could Down's syndrome be a model of accelerated ageing?
    Massaccesi L; Corsi MM; Baquero-Herrera CJ; Licastro F; Tringali C; Venerando B; Lombardo A; Alberghino A; Goi G
    Mech Ageing Dev; 2006 Apr; 127(4):324-31. PubMed ID: 16460783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging of the erythrocyte. XX. Decreased red cell life span in Down's syndrome.
    Bartosz G; Kedziora J
    Cell Biol Int Rep; 1982 Dec; 6(12):1119-22. PubMed ID: 6217903
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipid content in erythrocyte membranes in patients with Down's syndrome].
    Shvarts EI; Rezenberg OA
    Pediatriia; 1976 Nov; (11):68-70. PubMed ID: 136633
    [No Abstract]   [Full Text] [Related]  

  • 7. Down's syndrome: permeability of the erythrocyte membrane for spin-labeled non-electrolytes.
    Koter M; Kedziora J; Bartosz G; Leyko W
    Experientia; 1982 Dec; 38(12):1447-8. PubMed ID: 6217983
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythrocyte membrane changes of individuals with Down's syndrome in various stages of Alzheimer-type dementia.
    Bosman GJ; Visser FE; De Man AJ; Bartholomeus IG; De Grip WJ
    Neurobiol Aging; 1993; 14(3):223-8. PubMed ID: 8321389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of altered aspartyl residues in erythrocyte proteins from patients with Down's syndrome.
    Galletti P; De Bonis ML; Sorrentino A; Raimo M; D'Angelo S; Scala I; Andria G; D'Aniello A; Ingrosso D; Zappia V
    FEBS J; 2007 Oct; 274(20):5263-77. PubMed ID: 17892495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte-mediated scavenging of reactive oxygen metabolites generated by human polymorphonuclear leukocytes during phagocytosis: comparison between normal and Down's syndrome blood cells.
    Forslid J; Björkstén B; Hagersten K; Hed J
    Inflammation; 1989 Oct; 13(5):543-51. PubMed ID: 2530174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant enzymes and fatty acid status in erythrocytes of Down's syndrome patients.
    Pastor MC; Sierra C; Doladé M; Navarro E; Brandi N; Cabré E; Mira A; Serés A
    Clin Chem; 1998 May; 44(5):924-9. PubMed ID: 9590363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative enzymic determination of galactokinase activity in the erythrocyte haemolysate of patients with Down's syndrome (author's transl)].
    Lippross S; Menne F
    Z Klin Chem Klin Biochem; 1974 Oct; 12(10):449-52. PubMed ID: 4279510
    [No Abstract]   [Full Text] [Related]  

  • 13. Adenosine triphosphate and diphosphoglycerate levels in red blood cells from patients with Down's syndrome.
    Knull HR; Bronstein WW; Porter PJ
    Experientia; 1978 Sep; 34(9):1133-4. PubMed ID: 152715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies of physico-chemical properties and erythrocyte metabolism in children with Down's syndrome].
    Kedziora J; Hlyńczak AJ; Jeske J; Kański M
    Endokrynol Pol; 1972; 23(2):75-85. PubMed ID: 4260545
    [No Abstract]   [Full Text] [Related]  

  • 15. Red blood cell glucose metabolism in Down's syndrome.
    Magnani M; Stocchi V; Novelli G; Dachà M; Fornaini G
    Clin Physiol Biochem; 1987; 5(1):9-14. PubMed ID: 2953518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermosensitivity of red blood cells from Down's syndrome individuals.
    Przybylska M; Bryszewska M; K dziora J
    Bioelectrochemistry; 2000 Dec; 52(2):239-49. PubMed ID: 11129248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal degradation of erythrocyte membrane proteins in Down's syndrome.
    Gaczyńska M; Rosin J; Bartosz G; Kedziora J; Jeske J
    Hereditas; 1987; 106(1):151-3. PubMed ID: 2953697
    [No Abstract]   [Full Text] [Related]  

  • 18. Trace element profiles in individual blood cells from patients with Down's syndrome.
    Annerén G; Johansson E; Lindh U
    Acta Paediatr Scand; 1985 Mar; 74(2):259-63. PubMed ID: 3158149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The age-dependent incidence of Down's syndrome and the free-radical theory].
    Arbuzova SB
    Tsitol Genet; 1996; 30(5):27-35. PubMed ID: 9026987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of cholesterol sulphate in blood plasma and in erythrocyte membranes from individuals with Down's syndrome or diabetes mellitus type I.
    Przybylska M; Bryszewska M; Nowicka U; Szosland K; Kedziora J; Epand RM
    Clin Biochem; 1995 Dec; 28(6):593-7. PubMed ID: 8595707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.